7th Annual Healthcare M&A & Business Development

$499.00

SKU: HCP09587 Categories: , ,

Description

Report Code: HCP09587. September, 2009. Atlanta, GA

ARTICLE I

Healthcare Reform 2009: What Works, What Doesn’t and What to Expect A Roadmap for to the Perplexed

Michael Fine, MD
Managing Director
HealthAccess RI

ARTICLE II

Implications of Healthcare Reform on Private Equity Investment and M&A Strategies

Kristopher Brown
Partner
Dechert LLP

ARTICLE III

Global Corporation’s Strategy for US Healthcare Investments

Jerry Bratkovich
Executive Advisor, Healthcare Investments
Itochu International Inc.

ARTICLE IV

M&A in Healthcare

Steve Tisdell
Principal
Bridge Associates LLC

ARTICLE V

Develop an Asian Pacific Presence

Ames Gross
President
Pacific Bridge Medical

ARTICLE VI

Alliances versus M&A? What is Biotech To Do….

Hector G. Calzada, Jr.
Director
Deloitte Corporate Finance LLC

ARTICLE VII

Innovative Strategies for Getting the Deal Done: Avoiding Mistakes in the Transactional Process

Marc A. Cabrera
Managing Director
Morgan Joseph & Co., Inc.

ARTICLE VIII

Taking Advantage of the New Landscape in Healthcare IT and eRecords

David T. Gulian
President & CEO
Infologix, Inc.

Ron Ribitzky, MD
Chief Executive Officer
R&D Ribitzky

ARTICLE IX

Leveraging Health Information Technology to Deliver on the Promise of Patient-Centered Care

Charlene Underwood, M.B.A., FHIMSS
Director, Government & Industry Affairs, Health Services
Siemens Healthcare

ARTICLE X

New Technological Frontiers and Trends that Merit M&A or Corporate Development Consideration: Medical Devices & Diagnostics

Robert H. Raynor, PhD
Director, Corporate and Business Development
Beckman Coulter, Inc.

ARTICLE XI

How Do We Improve Operations in the Current Healthcare Environment?

Kevin Cross
Chief Operating Officer
Touchstone Medical Imaging , LLC

ARTICLE XII

Healthcare Business Development

Michelle Hood, FACHE
President and CEO
EMHS